Megamenu content

Learn more about how we innovate to bring therapies to patients that significantly improve their lives.

Find out about our diversified health care portfolio which includes some of the world’s best-known prescription medicines, vaccines and non-prescription products.

Our Products

Helping Communities

See how we support the people in the communities where we work and live through our community investment partnerships.

Helping Communities

Section 4

Enter a description for Section 4 here.

Link to top-level or promoted content

Section 5

Enter a description for Section 5 here.

Link to top-level or promoted content

Section 6

Enter a description for Section 6 here.

Link to top-level or promoted content

territory selector

SODIUM BICARBONATE INJECTION USP

Product Information

Prescribing Information (download PDF, 403KB)

Product Communication

June 30, 2017 Important Safety Information on Type I Recall Sodium Bicarbonate Inj 8.4% 50 mL vials - Risk of Infection Due to Potential Microbial Contamination (download PDF, 798KB)

June 23, 2017 NEWS REGARDING SODIUM BICARBONATE INJECTION 8.4% (download PDF, 798KB)

June 21, 2017 Second Notification (download PDF, 798KB)

June 20, 2017 Client Letter (download PDF, 798KB)

Canadian regulations limit the scope of information we are permitted to give on prescription drugs via the Internet or other means. Please consult a qualified health professional for more detailed information.

Please contact Pfizer Canada Medical Information at 1 800 463-6001 with any comments or inquiries.

If you encounter technical difficulties in viewing our product information please contact Pfizer.ca

Français

Megamenu content

territory selector

Header menu

Search form

SODIUM BICARBONATE INJECTION USP

Product Information

Product Communication

Footer menu

Megamenu content

territory selector

Header menu

Search form

You are here

SODIUM BICARBONATE INJECTION USP

Product Information

Product Communication

Footer menu